Corporate Tech Investors

Shenzhen Salubris Pharmaceuticals

Shenzhen Salubris Pharmaceuticals is a corporate entity that makes equity investment in companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Shenzhen Salubris Pharmaceuticals Co., Ltd (Salubris) is a comprehensive group pharmaceutical company that integrates pharmaceutical products research and development, production and business sales, which is founded in 1998 and listed in the Small and Medium Enterprise Board of Shenzhen Stock Exchange in 2009. Salubris is ranking top 10 in market value among Chinese pharmaceutical companies, and was named the most competitive domestic pharmaceutical listing corporation top 20 and awarded Top 10 Market Value Enterprises listed on SMEs Board.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/7/2022

Transaction History

Our records indicate that Shenzhen Salubris Pharmaceuticals invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Kevin YE

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Shenzhen Salubris Pharmaceuticals has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Shenzhen Hepalink Pharmaceutical | SHI International

Share this article

About Our Corporate Tech Investor Database

This corporate tech investment data comes via a partnership with VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary